Crinetics Pharmaceuticals Inc (CRNX)
44.79
+1.32
(+3.04%)
USD |
NASDAQ |
Jun 28, 16:00
44.71
-0.08
(-0.18%)
After-Hours: 20:00
Crinetics Pharmaceuticals Cash from Operations (Quarterly): -52.86M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -52.86M |
| December 31, 2023 | -38.52M |
| September 30, 2023 | -41.34M |
| June 30, 2023 | -45.74M |
| March 31, 2023 | -40.72M |
| December 31, 2022 | -35.21M |
| September 30, 2022 | -38.48M |
| June 30, 2022 | -27.98M |
| March 31, 2022 | -13.54M |
| December 31, 2021 | -22.90M |
| September 30, 2021 | -25.67M |
| June 30, 2021 | -19.95M |
| March 31, 2021 | -20.07M |
| December 31, 2020 | -15.94M |
| September 30, 2020 | -18.00M |
| Date | Value |
|---|---|
| June 30, 2020 | -15.86M |
| March 31, 2020 | -12.23M |
| December 31, 2019 | -13.45M |
| September 30, 2019 | -13.61M |
| June 30, 2019 | -12.57M |
| March 31, 2019 | -6.759M |
| December 31, 2018 | -6.009M |
| September 30, 2018 | -5.693M |
| June 30, 2018 | -4.35M |
| March 31, 2018 | -3.407M |
| December 31, 2017 | -2.511M |
| September 30, 2017 | -2.443M |
| June 30, 2017 | -2.199M |
| March 31, 2017 | -2.326M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-52.86M
Minimum
Mar 2024
-12.23M
Maximum
Mar 2020
-26.23M
Average
-21.48M
Median
Cash from Operations (Quarterly) Benchmarks
| Syndax Pharmaceuticals Inc | -83.55M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -3.654M |
| Theriva Biologics Inc | -4.881M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.309M |
| Cash from Financing (Quarterly) | 393.57M |
| Free Cash Flow | -184.45M |
| Free Cash Flow Per Share (Quarterly) | -0.7496 |
| Free Cash Flow to Equity (Quarterly) | -54.19M |
| Free Cash Flow Yield | -6.57% |